Skip to content

Novo Holdings A/S 13F Holdings · Q2 2026

Novo Holdings A/S reported 25 securities worth $1.72B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: EWTX (12.62%), ASML (10.97%), COAG (8.92%). Among its top 25 positions this quarter: 6 new, 2 added, 8 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1EWTXEDGEWISE THERAPEUTICS INC$217.4M12.62%5.3MHold
2ASMLASML HOLDING N V$188.9M10.97%94,946Hold
3COAGHEMAB THERAPEUTICS HLDGS INC$153.6M8.92%4.2MNew
4BNBROOKFIELD CORP$149.5M8.68%3.5MHold
5MPLTMAPLIGHT THERAPEUTICS INC$132.1M7.67%3.7MHold
6MIRMMIRUM PHARMACEUTICALS INC$131.7M7.65%1.1MTrimmed
7AVLNAVALYN PHARMACEUTICALS INC$127.8M7.42%3.9MNew
8CRMSALESFORCE INC$61.6M3.58%393,187Hold
9AVBPARRIVENT BIOPHARMA INC$52.1M3.03%1.5MTrimmed
10ELVNENLIVEN THERAPEUTICS INC$50.8M2.95%1.0MTrimmed
11CRNXCRINETICS PHARMACEUTICALS IN$49.4M2.87%1.3MTrimmed
12PHVSPHARVARIS N V$48.4M2.81%1.4MTrimmed
13FNDFLOOR & DECOR HLDGS INC$47.3M2.75%797,000New
14PCVXVAXCYTE INC$46.5M2.70%800,000Trimmed
15FDMT4D MOLECULAR THERAPEUTICS IN$43.2M2.51%3.2MTrimmed
16VRDNVIRIDIAN THERAPEUTICS INC$39.2M2.28%2.1MAdded
17CLDXCELLDEX THERAPEUTICS INC NEW$38.1M2.21%1.0MTrimmed
18ALMSALUMIS INC$31.0M1.80%1.1MNew
19XENEXENON PHARMACEUTICALS INC$29.3M1.70%485,438Hold
20BABAALIBABA GROUP HLDG LTD$24.7M1.43%257,327Hold
21DYNDYNE THERAPEUTICS INC$21.3M1.24%960,394New
22BBOTBRIDGEBIO ONCOLOGY THERAPEUT$17.1M1.00%2.2MAdded
23INSMINSMED INC$12.9M0.75%120,723New
24MQMARQETA INC$7.2M0.42%441,558Hold
25LNZALANZATECH GLOBAL INC$1.1M0.06%158,148Hold

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR